Studies on Aldosterone and Vascular Function
Primary Purpose
Inflammation
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
aldosterone
low or high sodium diet
placebo
Sponsored by

About this trial
This is an interventional diagnostic trial for Inflammation focused on measuring vascular endothelium, nitric oxide, aldosterone, vascular biology
Eligibility Criteria
Inclusion Criteria:
- Healthy subjects age >18 years
Exclusion Criteria:
- Any chronic medical disease or chronic use of medications
Sites / Locations
- Yale University School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Placebo Comparator
Placebo Comparator
Arm Label
A
B
C
D
Arm Description
Aldosterone plus low salt diet
Aldosterone plus high sodium diet
Placebo plus low sodium diet
placebo plus high sodium diet
Outcomes
Primary Outcome Measures
Flow mediated dilation brachial artery
Secondary Outcome Measures
Full Information
NCT ID
NCT00700479
First Posted
December 25, 2007
Last Updated
June 17, 2008
Sponsor
Yale University
Collaborators
Pfizer
1. Study Identification
Unique Protocol Identification Number
NCT00700479
Brief Title
Studies on Aldosterone and Vascular Function
Official Title
Studies on Aldosterone and Vascular Function
Study Type
Interventional
2. Study Status
Record Verification Date
June 2008
Overall Recruitment Status
Completed
Study Start Date
January 2006 (undefined)
Primary Completion Date
June 2008 (Actual)
Study Completion Date
June 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Yale University
Collaborators
Pfizer
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
A randomized crossover trial to determine the effects of sodium loading and aldosterone infusion on endothelial function in normal subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammation
Keywords
vascular endothelium, nitric oxide, aldosterone, vascular biology
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 1
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Experimental
Arm Description
Aldosterone plus low salt diet
Arm Title
B
Arm Type
Experimental
Arm Description
Aldosterone plus high sodium diet
Arm Title
C
Arm Type
Placebo Comparator
Arm Description
Placebo plus low sodium diet
Arm Title
D
Arm Type
Placebo Comparator
Arm Description
placebo plus high sodium diet
Intervention Type
Drug
Intervention Name(s)
aldosterone
Intervention Description
4 hour infusion
Intervention Type
Dietary Supplement
Intervention Name(s)
low or high sodium diet
Intervention Type
Drug
Intervention Name(s)
placebo
Intervention Description
placebo
Primary Outcome Measure Information:
Title
Flow mediated dilation brachial artery
Time Frame
0 and 4 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy subjects age >18 years
Exclusion Criteria:
Any chronic medical disease or chronic use of medications
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stuart Katz, MD
Organizational Affiliation
Yale School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale University School of Medicine
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06510
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Studies on Aldosterone and Vascular Function
We'll reach out to this number within 24 hrs